Epidemiology and economic repercussion of headache: An inquiery among the administrative and technical personnal of the Liège University;Épidémiologie et répercussions économiques des céphalées: Une enquête parmi le personnel administratif, technique et ouvrier (PATO) de l'Université de Liège

Revue Medicale de Liege

Volumn 63, Issue 5-6, 2008, Pages 310-314

  Gerardy P Y ^a   Fumal, A ^a   Schoenen, J ^a  

^a Centre Hospitalier Regional de La Citadelle   (Belgium)

Author keywords

Cost of illness; Epidemiology; Headache; Migraine

Indexed keywords

ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RIBOFLAVIN; TRIPTAN DERIVATIVE; VALPROIC ACID; VERAPAMIL;

ABSENTEEISM; BELGIUM; COST OF ILLNESS; ECONOMIC ASPECT; HEADACHE; HUMAN; INCIDENCE; MIGRAINE; PERSONNEL; PREVALENCE; PRODUCTIVITY; REVIEW; STRUCTURED QUESTIONNAIRE; UNIVERSITY; ADULT; ARTICLE; ECONOMICS; FEMALE; MALE; OCCUPATIONAL HEALTH;

ADULT; COST OF ILLNESS; FEMALE; HEADACHE; HUMANS; MALE; OCCUPATIONAL HEALTH;

EID: 47249095447     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. nd edition. Cephalalgia, 2004 , 24, 1-160.
2. Patel NV, Bigal ME, Kolodner KB, et al. - Prevalence and impact of migraine and probable migraine in a health plan. Neurology, 2004, 63, 1432-1438.
3. Fumal A, Gérardy PY, Schoenen J. - Actualités thérapeutiques dans la migraine. Rev Med Liege, 2008, 63, 315-329.
4. Fiane I, Haugland M, Stovner L, et al. - Sick leave is related to frequencies of migraine and non-migrainous headache-The HUNT Study. Cephalalgia, 2006, 26, 960-967.
5. Becker C, Brobert G, Almqvist P, et al. - Migraine incidence, comorbidity and health resource utilization in the UK. Cephalalgia, 2008, 28, 57-64.
6. Moens G, Johannik K, Verbeek C, et al. - The prevalence and characteristics of migraine among the Belgian working population. Acta Neurol Belg, 2007, 107, 84-90.
7. Stovner LJ, Zwart J, Hagen K, et al. - Epidemiology of headache in Europe. Eur J Neurol, 2006, 13, 333-345.
8. Lipton RB, Bigal ME. - The epidemiology of migraine. Am J Med Suppl, 2005, 118, 3-10.
9. Steiner T, Scher A, Stewart W, et al. - The prevalence and disability burden of adult migraine in England and their relationships to age, gender and ethnicity. Cephalalgia, 2003, 23, 519-527.
10. rd Edition. Lippincott Williams & Wilkins. Philadelphie. 2005, 17-26.
11. Berg J, Stovner LJ. - Cost of migraine and other headaches in Europe. Eur J Neurol, 2005, 12, 59-62.
12. Schoenen J. - Epidémiologie et impact de la migraine. Cahiers de Médecine du Travail, 1995, 32, 203-204.
13. World Health Organization. - The World Health Report 2001. Geneva. WHO.
14. Andlin-Sobocki P, Jonsson B, Wittchen HU, et al. - Cost of disorders of the brain in Europe. Eur J Neur, 2005, 12, 1-27.
15. Steiner T. - Lifting the burden : the global campaign against headache. Lancet, 2004, 3, 204-205.
16. Diamond S, Bigal ME, Silberstein S, et al. - Patterns of Diagnosis and Acute and Preventive Treatment for Migraine in the United States: Results from the American Migraine Prevalence and Prevention Study. Headache : J Head Pace Pain, 2007, 47, 355-363.
17. American Association for the Study of Headache. - Consensus Statement on Improving Migraine Management. Headache. J Head Face Pain, 1998, 38, 736-736.
18. Zwart J, Dyb G, Hagen K, et al. - Analgesic use : A predictor of chronic pain and medication overuse headache. The Head-HUNT Study. Neurology, 2003, 61, 160-164.
19. Limmroth V, Katsarava Z, Fritsche G. - Features of medication overuse headache following overuse of different acute headache drugs. Neurology, 2002, 59, 1011-1014.